USP-19 inhibitors (Progenra)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameUSP-19 inhibitors (Progenra)

Drug Alias Nameubiquitin specific protease 19 inhibitors (Progenra)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUbiquitin carboxyl-terminal hydrolase 19 inhibitors

TargetsUbiquitin carboxyl-terminal hydrolase 19

Therapy Area/IndicationsMuscular Atrophy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesProgenra Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesProgenra Inc

Active IndicationsN/A

Inactive IndicationsMuscular Atrophy

ATC CodeN/A